Cargando…
MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis
OBJECTIVE: MicroRNAs are promising biomarkers of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), but discrepant results between studies have so far hampered their use in clinical trials. We aim to assess all previously identified circulating microRNA signatures as potential bi...
Autores principales: | Kmetzsch, Virgilio, Latouche, Morwena, Saracino, Dario, Rinaldi, Daisy, Camuzat, Agnès, Gareau, Thomas, Le Ber, Isabelle, Colliot, Olivier, Becker, Emmanuelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639633/ https://www.ncbi.nlm.nih.gov/pubmed/36264717 http://dx.doi.org/10.1002/acn3.51674 |
Ejemplares similares
-
Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis
por: Kmetzsch, Virgilio, et al.
Publicado: (2021) -
Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias
por: Fournier, Clémence, et al.
Publicado: (2018) -
Factors influencing the age at onset in familial frontotemporal lobar dementia: Important weight of genetics
por: Barbier, Mathieu, et al.
Publicado: (2017) -
Expanding the genetics of amyotrophic lateral sclerosis and frontotemporal dementia
por: Schymick, Jennifer C, et al.
Publicado: (2012) -
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
por: Williams, Kelly L., et al.
Publicado: (2016)